Safety and clinical evaluation of dual inhibition with pertuzumab and trastuzumab in HER-2-positive breast cancer patients.
- Suppan, C. (Author)
- Daniel Steiner (Author)
- Klocker, E. V. (Author)
- Posch, F. (Author)
- EC Henzinger (Author)
- Stöger, H. (Author)
- Dandachi, N. (Author)
- Balic, M. (Author)
Activity: Talk, presentation or poster › Scientific talk or presentation › Online